WASHINGTON — A broad tariff on imported pharmaceuticals took effect at the end of September, and some biopharma companies and ...

US rare diseases specialist Ultragenyx Pharmaceutical announced it has entered into a definitive agreement to sell a Rare ...

Biohub, the nonprofit research institute combining AI and biology, has joined the US Department of Energy (DOE), the National ...

Retension Pharmaceuticals, Inc. (RTSN), a clinical-stage biopharmaceutical company developing treatments for cardiovascular diseases, announced the pricing of its upsized initial public offering of ...

AHMEDABAD: Gujarat is planning a Rs 100-crore investment over five years to establish the Marine Biotechnology Research & ...

The company believes this new manufacturing facility will contribute to the growing Bitterroot biotech corridor, while ...

I can sit through a biotech presentation and come away convinced that the company has discovered the answer to half the ...

Ready Therapeutic Programs Through Capital-Efficient DevelopmentPHILADELPHIA, Oct. 08, 2026 (GLOBE NEWSWIRE) -- . (NASDAQ: ...

The new membership pricing program gives eligible research buyers 50% off standard pricing on qualifying Kylo Peptides ...

Outsourcing, humanized models and PDX platforms boost drug-development efficiency; solid tumors drive demand, while Asia Pacific offers cost advantages and expanding biotech capacityDublin, Oct. 08, ...

Rocket Pharmaceuticals Inc. announced that it has entered into a credit facility agreement with Hercules Capital Inc. for up to $150 million.

Island Pharmaceuticals has issued 500,000 unquoted options under its employee incentive scheme, expiring on various dates and at various exercise prices. The options are subject to transfer ...